Literature DB >> 1245751

Phosphonoacetic acid treatment of shope fibroma and vaccinia virus skin infections in rabbits.

A E Friedman-Kien, A A Fondak, R J Klein.   

Abstract

The antiviral efficacy of phosphonoacetic acid (PAA) was studied in localized skin lesions of rabbits produced by the intradermal inoculation of vaccinia virus (VV) and of Shope fibroma virus (SFV). Systemic administration of PAA by intraperitoneal injections had no significant effect on the pustular lesions induced by VV or on the benign skin tumors caused by SFV. A complete suppression of the appearance of VV-induced pustular lesions was achieved by 2% PAA ointment applied twice daily for 4 days, starting 24 hr after virus inoculation. A significant effect against SFV-induced tumors was obtained by PAA ointment applied beginning either 24 or 72 hr after virus inoculation. A complete suppression of SFV-induced tumors was observed when a dose of 10 mg PAA was injected intralesionally once daily for 5 days, beginning treatment 24 hr after virus inoculation. A significant reduction of the intensity of the tumors was seen following the same treatment schedule but with a delay of 72 hr after virus inoculation or by reducing the length of treatment to 3 days or with a dose of 1 mg injected intradermally daily for 5 days. After the healing of the lesions, PAA-treated rabbits were resistant to reinfections to the same extent as those in which spontaneous healing had occurred.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245751     DOI: 10.1111/1523-1747.ep12481437

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.

Authors:  E R Kern; J T Richards; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

2.  Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate.

Authors:  E R Kern; L A Glasgow; J C Overall; J M Reno; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

3.  Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien; A A Fondak; E Buimovici-Klein
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

4.  Comparative studies of interferon and three antiviral agents on neurotropic and oncogenic herpesviruses.

Authors:  M D Daniel; L A Falk; N W King; R Tamulevich; J S Holland; J G Bekesi
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

5.  In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid.

Authors:  J M Goodrich; K W Lee; H C Hinze
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

6.  In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.

Authors:  J M Goodrich; K W Lee; H C Hinze
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.